Dendreon posts 4th-quarter loss versus year-ago profit

Mon Feb 25, 2013 8:00am EST

Feb 25 (Reuters) - Dendreon Corp reported a quarterly loss versus a year-ago profit on Monday as revenue fell and restructuring costs weighed on the biotechnology company.

The fourth-quarter loss was $38.7 million, or 26 cents per share, compared with a profit of $38.1 million, or 26 cents per share.

Quarterly revenue fell to $85.5 million from $202.1 million a year ago.

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see
Comments (1)
MyBloombergID wrote:
This article is totally misleading. If you check for data for the previous year, you’ll find there was a special event comprising the sale of intellectual property for $125 million. That’s what accounted for last years positive numbers. Without this background, your article is worthless.

Feb 25, 2013 8:50am EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.